Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease
- PMID: 12133652
- DOI: 10.1016/S0140-6736(02)09454-0
Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease
Abstract
Background: Although childbearing is known to protect against breast cancer, whether or not breastfeeding contributes to this protective effect is unclear.
Methods: Individual data from 47 epidemiological studies in 30 countries that included information on breastfeeding patterns and other aspects of childbearing were collected, checked, and analysed centrally, for 50302 women with invasive breast cancer and 96973 controls. Estimates of the relative risk for breast cancer associated with breastfeeding in parous women were obtained after stratification by fine divisions of age, parity, and women's ages when their first child was born, as well as by study and menopausal status.
Findings: Women with breast cancer had, on average, fewer births than did controls (2.2 vs 2.6). Furthermore, fewer parous women with cancer than parous controls had ever breastfed (71% vs 79%), and their average lifetime duration of breastfeeding was shorter (9.8 vs 15.6 months). The relative risk of breast cancer decreased by 4.3% (95% CI 2.9-5.8; p<0.0001) for every 12 months of breastfeeding in addition to a decrease of 7.0% (5.0-9.0; p<0.0001) for each birth. The size of the decline in the relative risk of breast cancer associated with breastfeeding did not differ significantly for women in developed and developing countries, and did not vary significantly by age, menopausal status, ethnic origin, the number of births a woman had, her age when her first child was born, or any of nine other personal characteristics examined. It is estimated that the cumulative incidence of breast cancer in developed countries would be reduced by more than half, from 6.3 to 2.7 per 100 women by age 70, if women had the average number of births and lifetime duration of breastfeeding that had been prevalent in developing countries until recently. Breastfeeding could account for almost two-thirds of this estimated reduction in breast cancer incidence.
Interpretation: The longer women breast feed the more they are protected against breast cancer. The lack of or short lifetime duration of breastfeeding typical of women in developed countries makes a major contribution to the high incidence of breast cancer in these countries.
Comment in
-
Breast cancer and breastfeeding.Lancet. 2003 Jan 11;361(9352):176; author reply 177. doi: 10.1016/S0140-6736(03)12207-6. Lancet. 2003. PMID: 12531603 No abstract available.
-
Breast cancer and breastfeeding.Lancet. 2003 Jan 11;361(9352):176-7; author reply 177. doi: 10.1016/S0140-6736(03)12208-8. Lancet. 2003. PMID: 12531604 No abstract available.
Comment on
-
Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.Lancet. 2002 Jul 20;360(9328):203-10. doi: 10.1016/S0140-6736(02)09456-4. Lancet. 2002. PMID: 12133654 Clinical Trial.
Similar articles
-
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.Lancet. 1997 Oct 11;350(9084):1047-59. Lancet. 1997. PMID: 10213546
-
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.Lancet. 2001 Oct 27;358(9291):1389-99. doi: 10.1016/S0140-6736(01)06524-2. Lancet. 2001. PMID: 11705483 Review.
-
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.Lancet. 1996 Jun 22;347(9017):1713-27. doi: 10.1016/s0140-6736(96)90806-5. Lancet. 1996. PMID: 8656904
-
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.Br J Cancer. 2002 Nov 18;87(11):1234-45. doi: 10.1038/sj.bjc.6600596. Br J Cancer. 2002. PMID: 12439712 Free PMC article.
-
Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis.J Hum Lact. 2017 May;33(2):422-434. doi: 10.1177/0890334416683676. Epub 2017 Feb 14. J Hum Lact. 2017. PMID: 28196329 Review.
Cited by
-
Risk of Gynecological and Breast Cancers in Workers Exposed to Diesel Exhaust: A Systematic Review and Meta-Analysis Of Cohort Studies.Med Lav. 2024 Jun 21;115(3):e2024011. doi: 10.23749/mdl.v115i3.15568. Med Lav. 2024. PMID: 38922840 Free PMC article.
-
Protocol for an observational study investigating hormones triggering the onset of sustained lactation: the INSIGHT study.BMJ Open. 2022 Aug 30;12(8):e062478. doi: 10.1136/bmjopen-2022-062478. BMJ Open. 2022. PMID: 36041762 Free PMC article.
-
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.Tumour Biol. 2016 Oct;37(10):12941-12957. doi: 10.1007/s13277-016-5168-x. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448308 Review.
-
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer.Cancers (Basel). 2020 Jul 19;12(7):1959. doi: 10.3390/cancers12071959. Cancers (Basel). 2020. PMID: 32707666 Free PMC article. Review.
-
Parity and expression of epithelial histopathologic markers in breast tissue.Eur J Cancer Prev. 2013 Sep;22(5):404-8. doi: 10.1097/CEJ.0b013e32835c7fc5. Eur J Cancer Prev. 2013. PMID: 23222412 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical